SCHEMBL6168219

SCHEMBL6168219

CC(=O)N1CCc2ccc(S(=O)(=O)n3ccc4ccccc43)cc2CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 11/20 0.54
HTT P42858 3/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
ALDH1A1 P00352 2/20 0.49
LMNA P02545 1/20 0.49
HPGD P15428 1/20 0.49
TSHR P16473 1/20 0.49
PKM P14618 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
MAPT P10636 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
RAPGEF4 Q8WZA2 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
CYP3A4 P08684 1/20 0.46
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6330455 0.93 HTR6 (0.50) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL6167732 0.80 HTR6 (0.65) HTR6HTTMEN1KMT2AALDH1A1
Hydrochloric Acid SCHEMBL6330320 0.79 HTR6 (0.64) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL6168062 0.75 ALDH1A1 (0.72) HTTMEN1KMT2AALDH1A1LMNA
SCHEMBL6328762 0.75 HTR6 (0.62) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL4035842 0.75 PNMT (0.49) HTTMEN1KMT2AALDH1A1LMNA
Hydrochloric Acid SCHEMBL6329781 0.74 HTR6 (0.61) HTR6HTTMEN1KMT2AALDH1A1
SCHEMBL4040738 0.73 NOTUM (0.47) HTTMEN1KMT2AALDH1A1LMNA
SCHEMBL4765964 0.72 HTR2C (0.64) MEN1KMT2AALDH1A1LMNAHPGD
SCHEMBL13688433 0.72 HTR6 (0.67) HTR6HTTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392316-B1 BENZO[D]AZEPINE DERIVATIVES AS 5-HT6 RECEPTOR ANTAGONISTS. SMITHKLINE BEECHAM PLC (GB) 2005-04-20 EP disclosed
US-20040192671-A1 Benzo[d]azepine derivatives as 5-ht6 receptor anatagonists SMITHKLINE BEECHAM P.L.C. (GB) 2004-09-30 US disclosed
EP-1392316-A1 BENZO[D]AZEPINE DERIVATIVES AS 5-HT6 RECEPTOR ANTAGONISTS. SMITHKLINE BEECHAM PLC (GB) 2004-03-03 EP disclosed
WO-2002089811-A1 BENZO[D]AZEPINE DERIVATIVES AS 5-HT6 RECEPTOR ANTAGONISTS. SMITHKLINE BEECHAM P.L.C. (GB) 2002-11-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192671-A1 Benzo[d]azepine derivatives as 5-ht6 receptor anatagonists HTR6, HTR5A, HTR1A HTR6 1/4885HTT 305/4885MEN1 2133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.